Comparative proteomics analysis of the proteins associated with laryngeal carcinoma-related gene 1

Laryngoscope

Volumn 116, Issue 2, 2006, Pages 224-230

  Zhang, Xiaopeng ^a   Xiao, Zhiqiang ^a,b   Chen, Zhuchu ^a,b,c,d   Li, Cui ^a   Li, Jianling ^a   Yanhui, Yu ^b   Yang, Fang ^a   Yang, Yixuan ^b   Oyang, Yongmei ^b  

^a BEIJING HOSPITAL   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c Xiangya Hospital ^*  (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

2 DE; Comparative proteomics; Differentially expressed proteins; ESI Q TOF MS MS; Laryngeal carcinoma; Laryngeal carcinoma related gene 1(LCRG1); MALDI TOF MS

Indexed keywords

LARYNGEAL CARCINOMA RELATED PROTEIN 1; MANGANESE SUPEROXIDE DISMUTASE; PHOSPHOGLYCERATE MUTASE; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; LCRG1 PROTEIN, HUMAN; TUMOR PROTEIN;

ARTICLE; CELL LINE; COMPARATIVE STUDY; COMPUTER PROGRAM; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; LARYNX CARCINOMA; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; MASS SPECTROMETRY; TUMOR CELL LINE; TWO DIMENSIONAL GEL ELECTROPHORESIS;

CELL LINE, TUMOR; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; MASS SPECTROMETRY; NEOPLASM PROTEINS; PROTEOMICS; TUMOR SUPPRESSOR PROTEINS;

EID: 33645781811     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000191470.71454.a1     Document Type: Article

References (15)

1. Li YJ, Chen ZC. Molecular cloning and characterization of LCRG1 a novel gene localized to the tumor suppressor locus D17S800-D17S930. Cancer Lett 2004;209:75-85.
2. Li YJ, Xie HL, Chen ZC, et al. Cloning and expression analysis of a laryngeal carcinoma related gene, LCRG1. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 2001;33:315-319.
3. Li YJ, Tian F, Chen ZC, et al. Isolation and identification of cDNA sequences differentially expressed in laryngeal carcinoma. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 2000;32:153-157.
4. Li YJ, Guan YJ, Xie HL, et al. Subcellular location and studies on biological characteristic of the protein encoded by laryngeal carcinoma related gene LCRG1. Ai Zheng 2001;20:911-915.
5. Li YJ, Zhang XP, Chen ZC, et al. LCRG1 suppresses tumor growth in vivo by liposome-mediated gene transfer. Chinese Journal of Cancer Research 2002;14:113-117.
6. Candiano G, Bruschi M, Musante L, et al. Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis 2004;25:1327-1333.
7. Ozeki M, Tamae D, Hou DX, et al. Response of cyclin B1 to ionizing radiation: regulation by NF-kappaB and mitochondrial antioxidant enzyme MnSOD. Anticancer Res 2004;24:2657-2663.
8. Lazennec G, Bresson D, Lucas A, et al. ER beta inhibits proliferation and invasion of breast cancer cells. Endocrinology 2001;142:4120-4130.
9. Lin M, van Golen KL. Rho-regulatory proteins in breast cancer cell motility and invasion. Breast Cancer Res Treat 2004;84:49-60.
10. Gibson RM, Gandhi PN, Tong X, et al. An activating mutant of Cdc42 that fails to interact with Rho GDP-dissociation inhibitor localizes to the plasma membrane and mediates actin reorganization. Exp Cell Res 2004;301:211-222.
11. Engel M, Mazurek S, Eigenbrodt E, et al. Phosphoglycerate Mutase-derived polypeptide inhibits glycolytic flux and induces cell growth arrest in tumor cell lines. J Biol Chem 2004;279:35803-35812.
12. Palombella VJ, Rando OJ, Goldberg AL, et al. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell 1994;78:773-785.
13. Moffat GJ, McLaren AW, Wolf CR. Involvement of Jun and Fos proteins in regulating transcriptional activation of the human pi class glutathione S-transferase gene in multidrug-resistant MCF7 breast cancer cells. J Biol Chem 1994;269:16397-16402.
14. Maki CG, Huibregtse JM, Howley PM. In vivo ubiquitination and proteasome-mediated degradation of p53(1). Cancer Res 1996;56:2649-2654.
15. Loda M, Cukor B, Tam SW, et al. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med 1997;3:231-234.